To the general public, the trial-and-error process of science and medicine may erode confidence, but without it, we’d have no science and medicine at all.
A recent retrospective study suggests that flu vaccines reduce risk of Alzheimer’s disease, but the study raises as many questions as it answers.
Statin therapy is known to raise Lp(a) particle concentration in some patients, but how does this impact the overall effect of these medications on ASCVD risk?
Blood from young mice has rejuvenating effects on old mice, but it’s too early to translate these results into treatments for humans.
A recent narrative review hypothesizes a key role for myokine disruption caused by physical inactivity.
A recently published NEJM paper appears to show that colonoscopy screenings do not reduce risk of colorectal cancer death. As is often the case, the results have been taken out of context and their implications grossly overestimated.
A quick search for “hangover prevention” will send you down a rabbit hole of advice. While staying hydrated and not drinking too much are obvious solutions, there’s a new hangover pill called Myrkl that’s garnering much attention. In this article, you’ll find out exactly what is in these pills, whether they might actually work (or not), and potential downsides.